To the best of our knowledge, among tubulins, only the aberrant expression of tubulin beta-3 (TUBB3) has been shown to correlate with the resistance to paclitaxel in ovarian, breast and lung cancers [112,113,114] and to docetaxel in gastric cancer [115]. This evidence concerns the gene TUBB3 and lung carcinoma.